Nonwalking response to fampridine in patients with multiple sclerosis in a real-world setting

OBJECTIVES: Mobility impairments constitute a long-term burden in patients with multiple sclerosis (MS). Currently there is evidence that the drug fampridine may improve nonwalking symptoms in MS patients. The main objective of this study is to analyze whether participants showing a beneficial walki...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Ther Adv Chronic Dis
Auteurs principaux: Rodriguez-Leal, Francisco Alejandro, Haase, Rocco, Akgün, Katja, Eisele, Judith, Proschmann, Undine, Schultheiss, Thorsten, Kern, Raimar, Ziemssen, Tjalf
Format: Artigo
Langue:Inglês
Publié: SAGE Publications 2019
Sujets:
Original Research
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC6475844/
https://ncbi.nlm.nih.gov/pubmed/31037211
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2040622319835136
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires